Last week, Eli Lillys orforglipron has become the first oral, non-peptide GLP-1 receptor agonist to clear a Phase 3 trial, showing strong efficacy in reducing A1C (up to 1.6%) and body weight (up to 7.9%) in people with type 2 diabetes
GLP-1 Medications and Your Vision: What You Should Know How GLP-1s Can Affect Eye Health Published March 2026 GLP1 medications short for glucagon-like peptide1 receptor agonists (GLP1 RAs) and GLP1 receptor agonists have become a popular option for people managing Type 2 diabetes, lowering blood sugar and helping with weight loss
These injections are very potent and show extremely positive results when it comes to losing those extra pounds once and for all
Nausea is one of the most frequently reported side effects, affecting approximately 50% of patients taking GLP-1 medications, whilst vomiting occurs in about 15-25% of patients
Trusted by thousands of GLP-1 users GLP-1 Support System Sample Pack GLP-1 Support System Sample Pack $19.99
This comprehensive support ensures that your weight loss is not only effective but also sustainable